Well, the sector did not do great yesterday. It started off as expected which was following the market higher but lagging a little and then it just went downhill all.

*** David Sobek is a disciplined value investor.  Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.***.

So it looks like the trade war with China is off, which should be good for the market in general. Whether that risk on appetite will translate into the biotech.

Some interesting moves and data coming out of the ASCO abstracts. There are some questions answered with these abstracts, although more questions remain unanswered. I suspect that many of the.

Drug pricing will not go away and I think that is going to be true going forward. We should not expect it to go away and at this point, one.

Not much going on this morning. The big feared Trump drug pricing speech was a giant nothing burger and anyone who has paid attention the past 18 months could have.